Last reviewed · How we verify

NCT04150185

Quality of Life and Psychology of Donors After Hepatectomy

Completed Last updated 4 November 2019
What this trial tests

trial testing Donor hepatectomy in Quality of Life in 52 participants. Completed in 1 September 2018.

Timeline
15 March 2012
Primary endpoint
31 August 2013
1 September 2018

Quick facts

Lead sponsorInstitute of Liver and Biliary Sciences, India
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date15 March 2012
Primary completion31 August 2013
Estimated completion1 September 2018

Drugs / interventions tested

Conditions studied

Sponsor

Institute of Liver and Biliary Sciences, India

Who can join

Eligibility, any sex, with Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Liver donation by a living donor is major surgery and has a profound effect on health-related quality of life and psychology. This study aims at evaluating those aspects of a donor for a period of five years after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Donor hepatectomy

Trials testing the same drug.

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Other Institute of Liver and Biliary Sciences, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04150185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing